lifestyle drugs – Benefits Canada.com https://www.benefitscanada.com Canada's most influential pension and benefits publication for decision-makers Wed, 01 May 2024 19:25:54 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.8 How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use of Ozempic https://www.benefitscanada.com/benefits/health-benefits/how-plan-sponsors-insurers-are-considering-coverage-of-weight-loss-drugs-amid-rising-use-of-ozempic/ Thu, 20 Jul 2023 13:00:32 +0000 https://www.benefitscanada.com/?p=141133 Canadian plan sponsors and insurers are revisiting how they classify obesity drugs under their benefits plans, amid plan members’ rising demand for Ozempic as a weight-loss treatment. Ozempic, also known under the generic name semaglutide, is a drug used to treat type 2 diabetes. However, the medication has also been credited as a weight-loss treatment, […]

The post How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use of Ozempic appeared first on Benefits Canada.com.

]]> 2023 Drug Plan Trends Report: How the repercussions of the pandemic are trickling down to drug plans https://www.benefitscanada.com/archives_/benefits-canada-archive/2023-drug-plan-trends-report-how-the-repercussions-of-the-pandemic-are-trickling-down-to-drug-plans/ Fri, 17 Mar 2023 12:56:14 +0000 https://www.benefitscanada.com/?p=135012 As the coronavirus pandemic enters its fourth year, it’s perhaps unsurprising that the health crisis has taken its toll on employee mental health. Scotiabank saw a notable rise in claims for mental-health drugs in 2022, says Ayman Alvi, the bank’s vice-president of global pension and benefits, noting the increased use of these medications aligns with […]

The post 2023 Drug Plan Trends Report: How the repercussions of the pandemic are trickling down to drug plans appeared first on Benefits Canada.com.

]]>